Woman suffers ‘life-threatening bowel injury’ due to Ozempic prosthesis

health

by Andrew Court

An Ozempic user will suffer from diarrhea for the rest of her life after suffering a serious bowel injury – allegedly caused by an injection of the widely popular weight loss drug.

The unidentified woman is one of dozens of people who have filed lawsuits against Novo Nordisk, the parent company of Ozempic and sister drug Wegovy, since November, according to a Daily Mail report on Saturday.

All of the plaintiffs claimed that the doses caused gastroparesis, a rare condition that affects the spontaneous movement of the stomach muscles.

Gastroparesis leaves patients with nausea, bloating and severe abdominal pain, according to the Mayo Clinic. It can also cause vomiting, weight loss, and malnutrition.

According to the lawsuit, the woman was diagnosed with a “life-threatening bowel injury” after using Ozempic, prompting surgeons to perform an eight-hour procedure in hopes of repairing her colon.

While she managed to survive the terrifying medical incident, she was told doctors told her she would be in pain “for the rest of her life” and “never have a solid bowel movement again.”

The woman is now accusing Novo Nordisk of “failing to properly warn of the risk of gastroparesis on drug packages.”

It is unclear whether she used the drug to lose weight or treat diabetes. It is also unknown how long she had been using the medication before her intestinal injury.

Both Ozempic and Wegovy were initially designed for people with type 2 diabetes, before doctors prescribed them to help patients lose weight.

These medications are injected once a week into the stomach, thigh, or arm, and semaglutides help The pancreas secretes the right amount of insulin when blood sugar levels are high.

“Semaglutide is produced while we eat. It tells the brain that we are full,” Dr. Katherine Saunders, a New York City physician, previously told The Washington Post.

“It helps people feel less hungry, feel full faster, and stay full longer — but it does so when we’re actually less “Full.”

While the vaccines have helped thousands of users lose weight by leaps and bounds, a separate lawsuit obtained by the Daily Mail claims one Wegovy user went a week without a bowel movement.

The plaintiff was taken to the hospital where doctors diagnosed her with gastroparesis.

The Washington Post has contacted Novo Nordisk for comment on the multiple lawsuits.

Meanwhile, weight-loss drugs made by other pharmaceutical giants have allegedly caused similar problems.

A third lawsuit seen by the Daily Mail has been filed against Eli Lilly, the maker of Mongaro, another injection that works in a similar way to Wegovy and Ozempic.

According to legal documents, the woman who used both Ozempic and Mounjaro “was diagnosed with gastroparesis, which caused her to vomit so much that some of her teeth fell out.”

According to the report, at least 9 other lawsuits have been filed against Eli Lilly.

Florida attorney Cameron Stevenson told the Daily Mail that his firm “currently has about 100 clients who have been diagnosed with gastroparesis” after using injectable medications. He believes the current allowances will be the tip of the iceberg.

“There is no doubt in my mind that there will be thousands of cases,” he declared.

Priya Hand, 23, a mother of two, is one of the Ozempic users who filed a lawsuit against Novo Nordisk.

She says she developed gastroparesis after being prescribed the weight-loss and diabetes medication Ozempic last May.

The Oklahoma native allegedly suffered from nausea, vomiting and constipation before ending up in intensive care on her fifth hospital visit.

“They said my body was so acidic that if I had waited another day I wouldn’t have made it through,” Hand announced in her suit. “It was scary. It was painful. I had never experienced that kind of pain in my entire life and I never want to go through that again.”

She urged the pharmaceutical company to be more transparent about potential side effects of the hugely popular drug.

“I think they should definitely announce more of the risks involved,” she wrote.